Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02466568
Title Study of Nivolumab in Combination With GM.CD40L Vaccine in Adenocarcinoma of the Lung
Recruitment Withdrawn
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors H. Lee Moffitt Cancer Center and Research Institute
Indications

lung adenocarcinoma

Therapies

Nivolumab

Age Groups: adult
Covered Countries


No variant requirements are available.